Voloridge Investment Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Buy |
770,527
+468,554
| +155% | +$6.56M | 0.04% | 524 |
|
|
2025
Q1 | $4.11M | Buy |
+301,973
| New | +$4.11M | 0.02% | 836 |
|
|
2024
Q3 | – | Sell |
-54,056
| Closed | -$1.26M | – | 1210 |
|
|
2024
Q2 | $1.26M | Sell |
54,056
-73,214
| -58% | -$1.7M | ﹤0.01% | 1021 |
|
|
2024
Q1 | $2.61M | Buy |
+127,270
| New | +$2.61M | 0.01% | 800 |
|
|
2023
Q3 | – | Sell |
-36,444
| Closed | -$1.08M | – | 1435 |
|
|
2023
Q2 | $1.08M | Buy |
36,444
+26,739
| +276% | +$789K | 0.01% | 1108 |
|
|
2023
Q1 | $224K | Sell |
9,705
-11,782
| -55% | -$271K | ﹤0.01% | 1301 |
|
|
2022
Q4 | $598K | Sell |
21,487
-20,869
| -49% | -$580K | ﹤0.01% | 1244 |
|
|
2022
Q3 | $1.3M | Sell |
42,356
-5,702
| -12% | -$175K | 0.01% | 1094 |
|
|
2022
Q2 | $1.41M | Buy |
48,058
+10,669
| +29% | +$314K | 0.01% | 1109 |
|
|
2022
Q1 | $1.2M | Buy |
37,389
+23,448
| +168% | +$754K | 0.01% | 1086 |
|
|
2021
Q4 | $622K | Sell |
13,941
-4,075
| -23% | -$182K | ﹤0.01% | 1374 |
|
|
2021
Q3 | $909K | Buy |
+18,016
| New | +$909K | 0.01% | 1311 |
|
|
2021
Q2 | – | Sell |
-27,958
| Closed | -$1.6M | – | 1636 |
|
|
2021
Q1 | $1.6M | Buy |
27,958
+13,884
| +99% | +$793K | 0.01% | 886 |
|
|
2020
Q4 | $1.18M | Sell |
14,074
-105,805
| -88% | -$8.86M | 0.01% | 915 |
|
|
2020
Q3 | $4.3M | Buy |
119,879
+109,476
| +1,052% | +$3.92M | 0.04% | 484 |
|
|
2020
Q2 | $252K | Buy |
+10,403
| New | +$252K | ﹤0.01% | 1162 |
|